ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Episurf Medical AB (publ) (EPIS-B.ST)
Episurf Medical AB (publ) stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Nasdaq Stockholm · Sweden
SEK 0.062▼ -3.12%
Prices as of Oct 27, 2026 · SEK
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Episurf Medical AB (publ) in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Episurf Medical AB (publ)
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Episurf Medical AB (publ) a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 0.054 and SEK 0.070; in 9 out of 10, between SEK 0.042 and SEK 0.088. Estimated annual volatility is 70%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- SEK 996M
- Market cap (USD)
- $100M
- 52-week high
- SEK 0.200
- 52-week low
- SEK 0.025
- Revenue (12 months)
- SEK 26.1M
- Gross margin
- 48.3%
- Operating margin
- 65.9%
- Net margin
- 0.0%
- Beta
- 0.91
What this means
ATLAS does not publish a fair value for EPIS-B.ST right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks EPIS-B.ST has traded between SEK 0.025 and SEK 0.200. Today it is 68.9% below that high and 154% above its low.
Its beta is 0.91: it moves roughly in line with the market.
About the company
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally.
Want to see everything about Episurf Medical AB (publ)?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Episurf Medical AB (publ) do?
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally.
What is the chance EPIS-B.ST goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, EPIS-B.ST ends the month between SEK 0.054 and SEK 0.070.
How big is Episurf Medical AB (publ) and what is its P/E ratio?
Episurf Medical AB (publ)'s market capitalization is SEK 996M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is EPIS-B.ST?
ATLAS estimates annual volatility at 70%. In a typical month, half of the outcomes end between SEK 0.054 and SEK 0.070.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer